The scale-up, promotion and use of oral pre-exposure prophylaxis (PrEP) in different settings and in different populations.

PrEP programmes and uptake: latest news

PrEP programmes and uptake news from aidsmap

More news

PrEP programmes and uptake news selected from other sources

  • South Africa sleeping on the most successful HIV weapons

    Oral pre-exposure prophylaxis (PrEP), taken as a once-daily pill, has been hailed the world over as one of the major HIV prevention interventions in the fight against AIDS. Yet, apart form sex workers, very few South Africans are using PrEP or even know it exists.

    03 December 2018 | Health-e
  • The unexpected effects of the HIV prevention pill

    PrEP is great at blocking HIV, but as its use grows, so do fears that people will be more sexually reckless and spread other STIs. But researchers are coming to think that the opposite could be true.

    29 November 2018 | Mosaic
  • No new infections during research on preventive HIV pill in Belgium

    According to the latest figures from Sciensano, 890 new diagnoses were made in Belgium last year, mainly in gay men and people from sub-Saharan Africa. This is a decrease of 27% compared to the peak of 2012.

    27 November 2018 | Institute of Tropical Medicine
  • Call for minimum standards of PrEP provision and monitoring in Europe

    Pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV infection when it is taken correctly—once a day during times when the likelihood of becoming infected with HIV is very high, or, for gay men and other men who have sex with men, before and after sexual activity, so-called event-driven PrEP.

    27 November 2018 | UNAIDS
  • PrEP in the USA: white people given preference 

    Nearly six times as many white people as black people are being prescribed pre-exposure prophylaxis (PrEP) in the USA, despite black people having a greater need. 

    26 November 2018 | AVERT
  • Substance use does not lower adherence to PrEP in MSM

    Study findings showed that substance use does not affect adherence to HIV pre-exposure prophylaxis, or PrEP, among men who have sex with men or transgender women.

    24 November 2018 | Healio
  • HIV Seroconversion Despite PrEP Therapy

    The tragedy of continued HIV transmission in the era of pre-exposure prophylaxis (PrEP) is explored in detail in a viewpoint article published in Clinical Infectious Diseases.1 The study evaluated a cohort of 14 young black men who have sex with men (MSM) in Atlanta, Georgia, who experienced HIV seroconversion despite administration of PrEP as part of the EleMENt Study.

    22 November 2018 | Infectious Disease Advisor
  • PrEP Messaging: Using radio to reach communities with oral PrEP messages

    Joel Odondi must be doing something right. The former chaplain for a girls’ school has become a trusted expert on HIV prevention to radio listeners across Kenya – delivering messages that correct misinformation, counter myths, explain scientific concepts, and frame public health debates on PrEP and a host of other issues related to HIV. Keeping an ear out especially for what young women need to hear, Odondi uses a powerful combination of responsiveness, accuracy and credibility to get the job done.

    13 November 2018 | Prepwatch
  • Los Angeles PrEP outreach campaign targets at-risk women

    The Los Angeles County Department of Public Health has created a series of videos to raise awareness among women about Pre-Exposure Prophylaxis as part of a campaign called GetPrEP LA.

    05 November 2018 | Daily Bulletin
  • PrEP: The battle against stigma

    FS asked 756 gay and bisexual men for their thoughts on PrEP. The results show a rift between the opinions of those who are taking PrEP and those who oppose it.

    29 October 2018 | GMFA
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.